EditorialGRANTS

New blood: Creative funding of disease-specific research

+ See all authors and affiliations

Science Translational Medicine  20 May 2015:
Vol. 7, Issue 288, pp. 288ed5
DOI: 10.1126/scitranslmed.aaa9513

Article Information

vol. 7 no. 288 288ed5

PubMed: 
Print ISSN: 
Online ISSN: 
History: 

    Author Information

    1. William E. Seaman,
    2. Richard M. Locksley and
    3. Michael J. Welsh
    1. William E. Seaman is Research Director of the American Asthma Foundation (AAF) and a Professor in the Departments of Medicine and of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA. Corresponding author. E-mail: bseaman{at}medicine.ucsf.edu
    2. Richard M. Locksley is Director, Sandler Asthma Basic Research Center, University of California, San Francisco; a member of the AAF Scientific Review Board; and a Professor in the Departments of Medicine and of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94143, USA.
    3. Michael J. Welsh is Chair of the AAF Scientific Review Board and a Professor in the Departments of Internal Medicine, Molecular Physiology and Biophysics, and Neurosurgery, University of Iowa Carver College of Medicine, Iowa City, IA 52242, USA.

    AltMetrics

    Article usage

    AbstractFullPDF
    May 20156475143
    Jun 201506432
    Jul 201501918
    Aug 201504912
    Sep 201506422
    Oct 201503715
    Nov 201503412
    Dec 20150209
    Jan 20160209
    Feb 20160175
    Mar 20160123
    Apr 20160132
    May 20160127
    Jun 2016095
    Jul 20160136
    Aug 20160121
    Sep 20160374
    Oct 2016093
    Nov 2016041
    Dec 2016060
    Jan 2017051
    Feb 2017071
    Mar 2017074

    Related Content